🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

RecruitingNAAges 18 Years - 75 YearsAllKafrelsheikh University
NCT06837844 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age from 18 to 75 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Scheduled for total knee arthroplasty under spinal anesthesia. Exclusion Criteria: * Patients with neurological or intellectual disability. * History of allergy to local anesthetics or dexmedetomidine . * Infection at the injection site. * Prolonged use of analgesic or sedative medications. * Coagulation abnormalities. * Pregnancy. * Obesity \[body mass index (BMI) \> 30 kg/m2\].
💊

What it tests

  • Intrathecal Dexmedetomidine
  • Adductor Canal Block
  • Intrathecal Dexmedetomidine + Adductor Canal Block
📍

Where

1 site
Kafrelsheikh University
Kafr ash Shaykh, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy